マーケットレポート詳細
お問い合わせは、アイコンをクリックしてご入力ください。別タブでフォームが開きます。
当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。
光線療法の世界市場規模は2023年で19億ドル、2034年に34億ドル、市場の平均年成長率は5.2%にて増加する見込みです。
当レポートでは、光線療法の市場予測-2034年、各種セグメント別市場分析(疾患タイプ別、光線療法タイプ別、国地域別、等)、パイプライン分析、主要製品/ブランド分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■光線療法の世界市場予測2020-2034年
・市場規模(US$)
■疾患タイプ別、市場-2034年
乾癬
・滴状乾癬
・逆乾癬
・膿疱性乾癬
・紅皮症性乾癬
・尋常性乾癬
にきび
・尋常性ざ瘡
・集簇性ざ瘡
・劇症性ざ瘡
・グラム陰性毛包炎
・酒さ性ざ瘡
・顔面皮膚膿皮症
※(市場規模US$)
■光線療法タイプ別、市場-2034年
・青色光線療法
・赤色光光線療法
・IPL光線療法
・ナローバンドUVB光線療法
・PUVA療法
※(市場規模US$)
■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・ASEAN、韓国
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収
■光線療法の主要企業プロフィール動向
Lifespan Health System
UCI Health
Buffalo Medical Group
Blackrock Health
The Private Phototherapy Clinic Ltd.
High Risk Skin Centre Clinic Massachusetts General Hospital
Signify Holding
GE HealthCare
Natus Medical Incorporated
(全145頁)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Phototherapy Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Phototherapy Treatment Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Phototherapy Treatment Market Analysis and Forecast, by Disease Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Disease Type, 2020-2034
6.3.1. Psoriasis
6.3.1.1. Guttate Psoriasis
6.3.1.2. Inverse Psoriasis
6.3.1.3. Pustular Psoriasis
6.3.1.4. Erythrodermic Psoriasis
6.3.1.5. Plaque Psoriasis
6.3.2. Acne
6.3.2.1. Acne Vulgaris
6.3.2.2. Acne Conglobata
6.3.2.3. Acne Fulminans
6.3.2.4. Gram-Negative Folliculitis
6.3.2.5. Acne Rosacea
6.3.2.6. Oyoderma Faciale
6.4. Market Attractiveness Analysis, by Disease Type
7. Global Phototherapy Treatment Market Analysis and Forecast, by Phototherapy Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Phototherapy Type, 2020-2034
7.3.1. Blue Light Phototherapy
7.3.2. Red Light Phototherapy
7.3.3. Intense Pulsed Light (IPL) Phototherapy
7.3.4. Narrowband UVB Phototherapy
7.3.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
7.4. Market Attractiveness Analysis, by Phototherapy Type
8. Global Phototherapy Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Homecare Settings
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Phototherapy Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Phototherapy Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Disease Type, 2020-2034
10.3.1. Psoriasis
10.3.1.1. Guttate Psoriasis
10.3.1.2. Inverse Psoriasis
10.3.1.3. Pustular Psoriasis
10.3.1.4. Erythrodermic Psoriasis
10.3.1.5. Plaque Psoriasis
10.3.2. Acne
10.3.2.1. Acne Vulgaris
10.3.2.2. Acne Conglobata
10.3.2.3. Acne Fulminans
10.3.2.4. Gram-Negative Folliculitis
10.3.2.5. Acne Rosacea
10.3.2.6. Oyoderma Faciale
10.4. Market Value Forecast, by Phototherapy Type, 2020-2034
10.4.1. Blue Light Phototherapy
10.4.2. Red Light Phototherapy
10.4.3. Intense Pulsed Light (IPL) Phototherapy
10.4.4. Narrowband UVB Phototherapy
10.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Dermatology Clinics
10.5.3. Homecare Settings
10.5.4. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Disease Type
10.7.2. By Phototherapy Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Phototherapy Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Disease Type, 2020-2034
11.3.1. Psoriasis
11.3.1.1. Guttate Psoriasis
11.3.1.2. Inverse Psoriasis
11.3.1.3. Pustular Psoriasis
11.3.1.4. Erythrodermic Psoriasis
11.3.1.5. Plaque Psoriasis
11.3.2. Acne
11.3.2.1. Acne Vulgaris
11.3.2.2. Acne Conglobata
11.3.2.3. Acne Fulminans
11.3.2.4. Gram-Negative Folliculitis
11.3.2.5. Acne Rosacea
11.3.2.6. Oyoderma Faciale
11.4. Market Value Forecast, by Phototherapy Type, 2020-2034
11.4.1. Blue Light Phototherapy
11.4.2. Red Light Phototherapy
11.4.3. Intense Pulsed Light (IPL) Phototherapy
11.4.4. Narrowband UVB Phototherapy
11.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Dermatology Clinics
11.5.3. Homecare Settings
11.5.4. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Disease Type
11.7.2. By Phototherapy Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Phototherapy Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Disease Type, 2020-2034
12.3.1. Psoriasis
12.3.1.1. Guttate Psoriasis
12.3.1.2. Inverse Psoriasis
12.3.1.3. Pustular Psoriasis
12.3.1.4. Erythrodermic Psoriasis
12.3.1.5. Plaque Psoriasis
12.3.2. Acne
12.3.2.1. Acne Vulgaris
12.3.2.2. Acne Conglobata
12.3.2.3. Acne Fulminans
12.3.2.4. Gram-Negative Folliculitis
12.3.2.5. Acne Rosacea
12.3.2.6. Oyoderma Faciale
12.4. Market Value Forecast, by Phototherapy Type, 2020-2034
12.4.1. Blue Light Phototherapy
12.4.2. Red Light Phototherapy
12.4.3. Intense Pulsed Light (IPL) Phototherapy
12.4.4. Narrowband UVB Phototherapy
12.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Dermatology Clinics
12.5.3. Homecare Settings
12.5.4. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Disease Type
12.7.2. By Phototherapy Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Phototherapy Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Disease Type, 2020-2034
13.3.1. Psoriasis
13.3.1.1. Guttate Psoriasis
13.3.1.2. Inverse Psoriasis
13.3.1.3. Pustular Psoriasis
13.3.1.4. Erythrodermic Psoriasis
13.3.1.5. Plaque Psoriasis
13.3.2. Acne
13.3.2.1. Acne Vulgaris
13.3.2.2. Acne Conglobata
13.3.2.3. Acne Fulminans
13.3.2.4. Gram-Negative Folliculitis
13.3.2.5. Acne Rosacea
13.3.2.6. Oyoderma Faciale
13.4. Market Value Forecast, by Phototherapy Type, 2020-2034
13.4.1. Blue Light Phototherapy
13.4.2. Red Light Phototherapy
13.4.3. Intense Pulsed Light (IPL) Phototherapy
13.4.4. Narrowband UVB Phototherapy
13.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Dermatology Clinics
13.5.3. Homecare Settings
13.5.4. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Disease Type
13.7.2. By Phototherapy Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Phototherapy Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Disease Type, 2020-2034
14.3.1. Psoriasis
14.3.1.1. Guttate Psoriasis
14.3.1.2. Inverse Psoriasis
14.3.1.3. Pustular Psoriasis
14.3.1.4. Erythrodermic Psoriasis
14.3.1.5. Plaque Psoriasis
14.3.2. Acne
14.3.2.1. Acne Vulgaris
14.3.2.2. Acne Conglobata
14.3.2.3. Acne Fulminans
14.3.2.4. Gram-Negative Folliculitis
14.3.2.5. Acne Rosacea
14.3.2.6. Oyoderma Faciale
14.4. Market Value Forecast, by Phototherapy Type, 2020-2034
14.4.1. Blue Light Phototherapy
14.4.2. Red Light Phototherapy
14.4.3. Intense Pulsed Light (IPL) Phototherapy
14.4.4. Narrowband UVB Phototherapy
14.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Dermatology Clinics
14.5.3. Homecare Settings
14.5.4. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Disease Type
14.7.2. By Phototherapy Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Lifespan Health System
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. UCI Health
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Buffalo Medical Group
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Blackrock Health
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. The Private Phototherapy Clinic Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. High Risk Skin Centre Clinic Massachusetts General Hospital
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Signify Holding
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. GE Healthcare
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Natus Medical Incorporated
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 01: Global Phototherapy Treatment Market Size (US$ Bn) Forecast, by Disease Type, 2020-2034
Table 02: Global Phototherapy Treatment Market Size (US$ Bn) Forecast, by Phototherapy Type, 2020-2034
Table 03: Global Phototherapy Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Phototherapy Treatment Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Phototherapy Treatment Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Phototherapy Treatment Market Size (US$ Bn) Forecast, by Disease Type, 2020-2034
Table 07: North America Phototherapy Treatment Market Size (US$ Bn) Forecast, by Phototherapy Type, 2020-2034
Table 08: North America Phototherapy Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Phototherapy Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Phototherapy Treatment Market Size (US$ Bn) Forecast, by Disease Type, 2020-2034
Table 11: Europe Phototherapy Treatment Market Size (US$ Bn) Forecast, by Phototherapy Type, 2020-2034
Table 12: Europe Phototherapy Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Phototherapy Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Phototherapy Treatment Market Size (US$ Bn) Forecast, by Disease Type, 2020-2034
Table 15: Asia Pacific Phototherapy Treatment Market Size (US$ Bn) Forecast, by Phototherapy Type, 2020-2034
Table 16: Asia Pacific Phototherapy Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Phototherapy Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Phototherapy Treatment Market Size (US$ Bn) Forecast, by Disease Type, 2020-2034
Table 19: Latin America Phototherapy Treatment Market Size (US$ Bn) Forecast, by Phototherapy Type, 2020-2034
Table 20: Latin America Phototherapy Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Phototherapy Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Phototherapy Treatment Market Size (US$ Bn) Forecast, by Disease Type, 2020-2034
Table 23: Middle East & Africa Phototherapy Treatment Market Size (US$ Bn) Forecast, by Phototherapy Type, 2020-2034
Table 24: Middle East & Africa Phototherapy Treatment Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Phototherapy Treatment Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Phototherapy Treatment Market Revenue (US$ Bn), by Disease Type, 2023
Figure 03: Global Phototherapy Treatment Market Value Share, by Disease Type, 2023
Figure 04: Global Phototherapy Treatment Market Revenue (US$ Bn), by Phototherapy Type, 2023
Figure 05: Global Phototherapy Treatment Market Value Share, by Phototherapy Type, 2023
Figure 06: Global Phototherapy Treatment Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Phototherapy Treatment Market Value Share, by End-user, 2023
Figure 08: Global Phototherapy Treatment Market Value Share, by Region, 2023
Figure 09: Global Phototherapy Treatment Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Phototherapy Treatment Market Value Share Analysis, by Disease Type, 2023 and 2034
Figure 11: Global Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Phototherapy Treatment Market Value Share Analysis, by Phototherapy Type, 2023 and 2034
Figure 13: Global Phototherapy Treatment Market Attractiveness Analysis, by Phototherapy Type, 2024-2034
Figure 14: Global Phototherapy Treatment Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Phototherapy Treatment Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Phototherapy Treatment Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Phototherapy Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Phototherapy Treatment Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Phototherapy Treatment Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Phototherapy Treatment Market Value Share Analysis, by Disease Type, 2023 and 2034
Figure 22: North America Phototherapy Treatment Market Value Share Analysis, by Phototherapy Type, 2023 and 2034
Figure 23: North America Phototherapy Treatment Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Phototherapy Treatment Market Attractiveness Analysis, by Phototherapy Type, 2024-2034
Figure 26:North America Phototherapy Treatment Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Phototherapy Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Phototherapy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Phototherapy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Phototherapy Treatment Market Value Share Analysis, by Disease Type, 2023 and 2034
Figure 31: Europe Phototherapy Treatment Market Value Share Analysis, by Phototherapy Type, 2023 and 2034
Figure 32: Europe Phototherapy Treatment Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Phototherapy Treatment Market Attractiveness Analysis, by Phototherapy Type, 2024-2034
Figure 35: Europe Phototherapy Treatment Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Phototherapy Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Phototherapy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Phototherapy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Phototherapy Treatment Market Value Share Analysis, by Disease Type, 2023 and 2034
Figure 40: Asia Pacific Phototherapy Treatment Market Value Share Analysis, by Phototherapy Type, 2023 and 2034
Figure 41: Asia Pacific Phototherapy Treatment Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Phototherapy Treatment Market Attractiveness Analysis, by Phototherapy Type, 2024-2034
Figure 44: Asia Pacific Phototherapy Treatment Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Phototherapy Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Phototherapy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Phototherapy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Phototherapy Treatment Market Value Share Analysis, by Disease Type, 2023 and 2034
Figure 49: Latin America Phototherapy Treatment Market Value Share Analysis, by Phototherapy Type, 2023 and 2034
Figure 50: Latin America Phototherapy Treatment Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Phototherapy Treatment Market Attractiveness Analysis, by Phototherapy Type, 2024-2034
Figure 53: Latin America Phototherapy Treatment Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Phototherapy Treatment Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Phototherapy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Phototherapy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Phototherapy Treatment Market Value Share Analysis, by Disease Type, 2023 and 2034
Figure 58: Middle East & Africa Phototherapy Treatment Market Value Share Analysis, by Phototherapy Type, 2023 and 2034
Figure 59: Middle East & Africa Phototherapy Treatment Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Phototherapy Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Phototherapy Treatment Market Attractiveness Analysis, by Phototherapy Type, 2024-2034
Figure 62: Middle East & Africa Phototherapy Treatment Market Attractiveness Analysis, by End-user, 2024-2034